Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Bernard Lebleu

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Anatomy

Chemicals & Drugs

Living Beings

Concepts & Ideas

Molecular Sequence Data

Physiology

Virus Replication

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
19
Bisbal, Catherine
19
Silhol, Michelle
17
Salehzada, Tamim
15
Abes, Saïd
12
Gait, Michael
9
Robbins, Ian
8
Moulton, Hong
8
Bayard, BA
8
THIERRY, Alain
7
Blanchard, Jean-Marie
7
Arzumanov, Andrey
7
Piechaczyk, Marc
6
Prevot, Paul
6
Martinand, C
6
Leserman, Lee

Sign-in to see all Coauthors

Publications

TOP 3
Barratt Gillian; Betbeder Didier; Lebleu Bernard
Challenges for nanotechnology in delivery imaging. Preface.
Ivanova Gabriela D; Arzumanov Andrey; Abes Rachida; Yin Haifang; Wood Matthew J A; Lebleu Bernard; Gait Michael J
Improved cell-penetrating peptide-PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle.
Abes Rachida; Moulton Hong M; Clair Philippe; Yang Sung-Tae; Abes Said; Melikov Kamran; Prevot Paul; Youngblood Derek S; Iversen Patrick L; Chernomordik Leonid V; Lebleu Bernard
Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure-activity studies.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Bernard Lebleu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Barratt Gillian; Betbeder Didier; Lebleu Bernard
Challenges for nanotechnology in delivery imaging. Preface.
International journal of pharmaceutics 2009;379(2):199-200.
2008: Ivanova Gabriela D; Arzumanov Andrey; Abes Rachida; Yin Haifang; Wood Matthew J A; Lebleu Bernard; Gait Michael J
Improved cell-penetrating peptide-PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle.
Nucleic acids research 2008;36(20):6418-28.
2008: Abes Rachida; Moulton Hong M; Clair Philippe; Yang Sung-Tae; Abes Said; Melikov Kamran; Prevot Paul; Youngblood Derek S; Iversen Patrick L; Chernomordik Leonid V; Lebleu Bernard
Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure-activity studies.
Nucleic acids research 2008;36(20):6343-54.
2008: Abes R; Arzumanov A; Moulton H; Abes S; Ivanova G; Gait M J; Iversen P; Lebleu B
Arginine-rich cell penetrating peptides: design, structure-activity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides.
Journal of peptide science : an official publication of the European Peptide Society 2008;14(4):455-60.
2008: Lebleu Bernard; Moulton Hong M; Abes Rachida; Ivanova Gabriela D; Abes Said; Stein David A; Iversen Patrick L; Arzumanov Andrey A; Gait Michael J
Cell penetrating peptide conjugates of steric block oligonucleotides.
Advanced drug delivery reviews 2008;60(4-5):517-29.
2008: Ivanova Gabriela D; Fabani Martin M; Arzumanov Andrey A; Abes Rachida; Yin Haifang; Lebleu Bernard; Wood Matthew; Gait Michael J
PNA-peptide conjugates as intracellular gene control agents.
Nucleic acids symposium series (2004) 2008;(52):31-2.
2007: Resina Sarah; Abes Saïd; Turner John J; Prevot Paul; Travo Adrian; Clair Philippe; Gait Michael J; Thierry Alain R; Lebleu Bernard
Lipoplex and peptide-based strategies for the delivery of steric-block oligonucleotides.
International journal of pharmaceutics 2007;344(1-2):96-102.
2007: Meryet-Figuières M; Resina S; Lavigne C; Barlovatz-Meimon G; Lebleu B; Thierry A R
Inhibition of PAI-1 expression in breast cancer carcinoma cells by siRNA at nanomolar range.
Biochimie 2007;89(10):1228-33.
2007: Moulton H M; Fletcher S; Neuman B W; McClorey G; Stein D A; Abes S; Wilton S D; Buchmeier M J; Lebleu B; Iversen P L
Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo.
Biochemical Society transactions 2007;35(Pt 4):826-8.
2007: Abes R; Arzumanov A A; Moulton H M; Abes S; Ivanova G D; Iversen P L; Gait M J; Lebleu B
Cell-penetrating-peptide-based delivery of oligonucleotides: an overview.
Biochemical Society transactions 2007;35(Pt 4):775-9.
2007: Resina Sarah; Kole Ryszard; Travo Adrian; Lebleu Bernard; Thierry Alain R
Switching on transgene expression by correcting aberrant splicing using multi-targeting steric-blocking oligonucleotides.
The journal of gene medicine 2007;9(6):498-510.
2007: Abes S; Moulton H; Turner J; Clair P; Richard J P; Iversen P; Gait M J; Lebleu B
Peptide-based delivery of nucleic acids: design, mechanism of uptake and applications to splice-correcting oligonucleotides.
Biochemical Society transactions 2007;35(Pt 1):53-5.
2007: Abes Saïd; Turner John J; Ivanova Gabriela D; Owen David; Williams Donna; Arzumanov Andrey; Clair Philippe; Gait Michael J; Lebleu Bernard
Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide.
Nucleic acids research 2007;35(13):4495-502.
2007: Debart Françoise; Abes Saïd; Deglane Gaelle; Moulton Hong M; Clair Philippe; Gait Michael J; Vasseur Jean-Jacques; Lebleu Bernard
Chemical modifications to improve the cellular uptake of oligonucleotides.
Current topics in medicinal chemistry 2007;7(7):727-37.
2006: Wolf Yvonne; Pritz Stephan; Abes Saïd; Bienert Michael; Lebleu Bernard; Oehlke Johannes
Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides.
Biochemistry 2006;45(50):14944-54.
2006: Abes Saïd; Moulton Hong M; Clair Philippe; Prevot Paul; Youngblood Derek S; Wu Rebecca P; Iversen Patrick L; Lebleu Bernard
Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.
Journal of controlled release : official journal of the Controlled Release Society 2006;116(3):304-13.
2006: Hecke Anneke; Brooks Hilary; Meryet-Figuière Matthieu; Minne Stephanie; Konstantinides Stavros; Hasenfuss Gerd; Lebleu Bernard; Schäfer Katrin
Successful silencing of plasminogen activator inhibitor-1 in human vascular endothelial cells using small interfering RNA.
Thrombosis and haemostasis 2006;95(5):857-64.
2006: Deglane Gaëlle; Abes Saïd; Michel Thibaut; Prévot Paul; Vives Eric; Debart Françoise; Barvik Ivan; Lebleu Bernard; Vasseur Jean-Jacques
Impact of the guanidinium group on hybridization and cellular uptake of cationic oligonucleotides.
Chembiochem : a European journal of chemical biology 2006;7(4):684-92.
2006: Thierry Alain R; Abes Said; Resina Sarah; Travo Adrian; Richard Jean Philippe; Prevot Paul; Lebleu Bernard
Comparison of basic peptides- and lipid-based strategies for the delivery of splice correcting oligonucleotides.
Biochimica et biophysica acta 2006;1758(3):364-74.
2006: Abes Saïd; Williams Donna; Prevot Paul; Thierry Alain; Gait Michael J; Lebleu Bernard
Endosome trapping limits the efficiency of splicing correction by PNA-oligolysine conjugates.
Journal of controlled release : official journal of the Controlled Release Society 2006;110(3):595-604.
2005: Maurel Frédéric; Debart Françoise; Cavelier Florine; Thierry Alain R; Lebleu Bernard; Vasseur Jean-Jacques; Vivès Eric
Toward high yield synthesis of peptide-oligonucleotide chimera through a disulfide bridge: a simplified method for oligonucleotide activation.
Bioorganic & medicinal chemistry letters 2005;15(22):5084-7.
2005: Overhoff Marita; Alken Martina; Far Rosel Kretschmer-Kazemi; Lemaitre Marc; Lebleu Bernard; Sczakiel Georg; Robbins Ian
Local RNA target structure influences siRNA efficacy: a systematic global analysis.
Journal of molecular biology 2005;348(4):871-81.
2005: Richard Jean Philippe; Melikov Kamran; Brooks Hilary; Prevot Paul; Lebleu Bernard; Chernomordik Leonid V
Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors.
The Journal of biological chemistry 2005;280(15):15300-6.
2005: Brooks Hilary; Lebleu Bernard; Vivès Eric
Tat peptide-mediated cellular delivery: back to basics.
Advanced drug delivery reviews 2005;57(4):559-77.
2005: Tiev Kiet Phong; Briant Mickael; Ziani Mohamed; Cabane Jean; Demettre Edith; Lebleu Bernard
Variability of the RNase L isoform ratio (37 kiloDaltons/83 kiloDaltons) in diagnosis of chronic fatigue syndrome.
Clinical and diagnostic laboratory immunology 2005;12(2):366.
2005: Turner John J; Ivanova Gabriela D; Verbeure Birgit; Williams Donna; Arzumanov Andrey A; Abes Saïd; Lebleu Bernard; Gait Michael J
Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells.
Nucleic acids research 2005;33(21):6837-49.
2004: Lavigne Carole; Lunardi-Iskandar Yanto; Lebleu Bernard; Thierry Alain R
Cationic liposomes/lipids for oligonucleotide delivery: application to the inhibition of tumorigenicity of Kaposi's sarcoma by vascular endothelial growth factor antisense oligodeoxynucleotides.
Methods in enzymology 2004;387():189-210.
2003: Michel Thibaut; Martinand-Mari Camille; Debart Françoise; Lebleu Bernard; Robbins Ian; Vasseur Jean-Jacques
Cationic phosphoramidate alpha-oligonucleotides efficiently target single-stranded DNA and RNA and inhibit hepatitis C virus IRES-mediated translation.
Nucleic acids research 2003;31(18):5282-90.
2003: Thierry Alain R; Vives Eric; Richard Jean-Philippe; Prevot Paul; Martinand-Mari Camille; Robbins Ian; Lebleu Bernard
Cellular uptake and intracellular fate of antisense oligonucleotides.
Current opinion in molecular therapeutics 2003;5(2):133-8.
2003: Vivès E; Richard J-P; Rispal C; Lebleu B
TAT peptide internalization: seeking the mechanism of entry.
Current protein & peptide science 2003;4(2):125-32.
2003: Tiev Kiet Phong; Demettre Edith; Ercolano Philippe; Bastide Lionel; Lebleu Bernard; Cabane Jean
RNase L levels in peripheral blood mononuclear cells: 37-kilodalton/83-kilodalton isoform ratio is a potential test for chronic fatigue syndrome.
Clinical and diagnostic laboratory immunology 2003;10(2):315-6.
2003: Richard Jean Philippe; Melikov Kamran; Vives Eric; Ramos Corinne; Verbeure Birgit; Gait Mike J; Chernomordik Leonid V; Lebleu Bernard
Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake.
The Journal of biological chemistry 2003;278(1):585-90.
2003: Martinand-Mari Camille; Lebleu Bernard; Robbins Ian
Oligonucleotide-based strategies to inhibit human hepatitis C virus.
Oligonucleotides 2003;13(6):539-48.
2002: Demettre Edith; Bastide Lionel; D'Haese Anne; De Smet Karen; De Meirleir Kenny; Tiev Kiet P; Englebienne Patrick; Lebleu Bernard
Ribonuclease L proteolysis in peripheral blood mononuclear cells of chronic fatigue syndrome patients.
The Journal of biological chemistry 2002;277(38):35746-51.
2002: De Meirleir Kenny; Suhadolnik Robert J; Lebleu Bernard; Englebienne Patrick
Antiviral pathway activation in chronic fatigue syndrome and acute infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(10):1420-1; author reply 1421-2.
2002: Shetzline Susan E; Martinand-Mari Camille; Reichenbach Nancy L; Buletic Zivjena; Lebleu Bernard; Pfleiderer Wolfgang; Charubala Ramamurthy; De Meirleir Kenny; De Becker Pascale; Peterson Daniel L; Herst C V T; Englebienne Patrick; Suhadolnik Robert J
Structural and functional features of the 37-kDa 2-5A-dependent RNase L in chronic fatigue syndrome.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2002;22(4):443-56.
2002: Silhol Michelle; Tyagi Mudit; Giacca Mauro; Lebleu Bernard; Vivès Eric
Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat.
European journal of biochemistry / FEBS 2002;269(2):494-501.
2001: Le Roy F; Bisbal C; Silhol M; Martinand C; Lebleu B; Salehzada T
The 2-5A/RNase L/RNase L inhibitor (RLI) [correction of (RNI)] pathway regulates mitochondrial mRNAs stability in interferon alpha-treated H9 cells.
The Journal of biological chemistry 2001;276(51):48473-82.
2001: Bisbal C; Salehzada T; Silhol M; Martinand C; Le Roy F; Lebleu B
The 2-5A/RNase L pathway and inhibition by RNase L inhibitor (RLI).
Methods in molecular biology (Clifton, N.J.) 2001;160():183-98.
2000: Malchère C; Verheijen J; van der Laan S; Bastide L; van Boom J; Lebleu B; Robbins I
A short phosphodiester window is sufficient to direct RNase H-dependent RNA cleavage by antisense peptide nucleic acid.
Antisense & nucleic acid drug development 2000;10(6):463-8.
2000: De Meirleir K; Bisbal C; Campine I; De Becker P; Salehzada T; Demettre E; Lebleu B
A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome.
The American journal of medicine 2000;108(2):99-105.
2000: Robbins I; Lebleu B
Vesicular stomatitis virus as model system for studies of antisense oligonucleotide translation arrest.
Methods in enzymology 2000;313():189-203.
1999: Laktionov P; Dazard J E; Piette J; Vives E; Rykova E; Vlassov V; Lebleu B
Uptake of oligonucleotides by keratinocytes.
Nucleosides & nucleotides 1999;18(6-7):1697-9.
1999: Laktionov P P; Dazard J E; Vives E; Rykova E Y; Piette J; Vlassov V V; Lebleu B
Characterisation of membrane oligonucleotide-binding proteins and oligonucleotide uptake in keratinocytes.
Nucleic acids research 1999;27(11):2315-24.
1999: Bastide L; Boehmer P E; Villani G; Lebleu B
Inhibition of a DNA-helicase by peptide nucleic acids.
Nucleic acids research 1999;27(2):551-4.
1999: Martinand C; Montavon C; Salehzada T; Silhol M; Lebleu B; Bisbal C
RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells.
Journal of virology 1999;73(1):290-6.
1998: Martinand C; Salehzada T; Silhol M; Lebleu B; Bisbal C
The RNase L inhibitor (RLI) is induced by double-stranded RNA.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1998;18(12):1031-8.
1998: Robbins I; Mitta G; Vichier-Guerre S; Sobol R; Ubysz A; Rayner B; Lebleu B
Selective mRNA degradation by antisense oligonucleotide-2,5A chimeras: involvement of RNase H and RNase L.
Biochimie 1998;80(8-9):711-20.
1998: Martinand C; Salehzada T; Silhol M; Lebleu B; Bisbal C
RNase L inhibitor (RLI) antisense constructions block partially the down regulation of the 2-5A/RNase L pathway in encephalomyocarditis-virus-(EMCV)-infected cells.
European journal of biochemistry / FEBS 1998;254(2):248-55.
1998: Gee J E; Robbins I; van der Laan A C; van Boom J H; Colombier C; Leng M; Raible A M; Nelson J S; Lebleu B
Assessment of high-affinity hybridization, RNase H cleavage, and covalent linkage in translation arrest by antisense oligonucleotides.
Antisense & nucleic acid drug development 1998;8(2):103-11.
1998: Benoit De Coignac A; Bisbal C; Lebleu B; Salehzada T
cDNA cloning and expression analysis of the murine ribonuclease L inhibitor.
Gene 1998;209(1-2):149-56.
1997: Vivès E; Brodin P; Lebleu B
A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus.
The Journal of biological chemistry 1997;272(25):16010-7.
1997: Lebleu B; Robbins I; Bastide L; Vives E; Gee J E
Pharmacokinetics of oligonucleotides in cell culture.
Ciba Foundation symposium 1997;209():47-54; discussion 54-9.
1995: Bordier B; Perala-Heape M; Degols G; Lebleu B; Litvak S; Sarih-Cottin L; Hélène C
Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: comparative study in cell-free assays and in HIV-infected cells.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(20):9383-7.
1995: Bisbal C; Martinand C; Silhol M; Lebleu B; Salehzada T
Cloning and characterization of a RNAse L inhibitor. A new component of the interferon-regulated 2-5A pathway.
The Journal of biological chemistry 1995;270(22):13308-17.
1994: Bongartz J P; Aubertin A M; Milhaud P G; Lebleu B
Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide.
Nucleic acids research 1994;22(22):4681-8.
1994: Degols G; Clarenc J P; Lebleu B; Léonetti J P
Reversible inhibition of gene expression by a psoralen functionalized triple helix forming oligonucleotide in intact cells.
The Journal of biological chemistry 1994;269(24):16933-7.
1994: Degols G; Devaux C; Lebleu B
Oligonucleotide-poly(L-lysine)-heparin complexes: potent sequence-specific inhibitors of HIV-1 infection.
Bioconjugate chemistry 1994;5(1):8-13.
1993: Salehzada T; Silhol M; Steff A M; Lebleu B; Bisbal C
2',5'-Oligoadenylate-dependent RNase L is a dimer of regulatory and catalytic subunits.
The Journal of biological chemistry 1993;268(11):7733-40.
1993: Clarenc J P; Lebleu B; Léonetti J P
Characterization of the nuclear binding sites of oligodeoxyribonucleotides and their analogs.
The Journal of biological chemistry 1993;268(8):5600-4.
1993: Clarenc J P; Degols G; Leonetti J P; Milhaud P; Lebleu B
Delivery of antisense oligonucleotides by poly(L-lysine) conjugation and liposome encapsulation.
Anti-cancer drug design 1993;8(1):81-94.
1993: Morvan F; Porumb H; Degols G; Lefebvre I; Pompon A; Sproat B S; Rayner B; Malvy C; Lebleu B; Imbach J L
Comparative evaluation of seven oligonucleotide analogues as potential antisense agents.
Journal of medicinal chemistry 1993;36(2):280-7.
1993: Leonetti J P; Degols G; Clarenc J P; Mechti N; Lebleu B
Cell delivery and mechanisms of action of antisense oligonucleotides.
Progress in nucleic acid research and molecular biology 1993;44():143-66.
1992: Degols G; Leonetti J P; Lebleu B
Sequence-specific activity of antisense oligonucleotides conjugated to poly (L-lysine) carriers.
Annals of the New York Academy of Sciences 1992;660():331-3.
1992: Degols G; Leonetti J P; Milhaud P; Mechti N; Lebleu B
Antisense inhibitors of HIV: problems and perspectives.
Antiviral research 1992;17(4):279-87.
1992: Lebleu B; Clarenc J P; Degols G; Leonetti J P; Milhaud P
[Control of gene expression by antisense nucleic acids]
Comptes rendus des séances de la Société de biologie et de ses filiales 1992;186(5):560-6.
1992: Degols G; Leonetti J P; Benkirane M; Devaux C; Lebleu B
Poly(L-lysine)-conjugated oligonucleotides promote sequence-specific inhibition of acute HIV-1 infection.
Antisense research and development 1992;2(4):293-301.
1991: Milhaud P G; Machy P; Colote S; Lebleu B; Leserman L
Free and liposome-encapsulated double-stranded RNAs as inducers of interferon, interleukin-6, and cellular toxicity.
Journal of interferon research 1991;11(5):261-5.
1991: Salehzada T; Silhol M; Lebleu B; Bisbal C
Regeneration of enzyme activity after western blot: activation of RNase L by 2-5A on filter--importance for its detection.
Analytical biochemistry 1991;196(2):410-4.
1991: Mechti N; Piechaczyk M; Blanchard J M; Jeanteur P; Lebleu B
Sequence requirements for premature transcription arrest within the first intron of the mouse c-fos gene.
Molecular and cellular biology 1991;11(5):2832-41.
1991: Leonetti J P; Mechti N; Degols G; Gagnor C; Lebleu B
Intracellular distribution of microinjected antisense oligonucleotides.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(7):2702-6.
1991: Salehzada T; Silhol M; Lebleu B; Bisbal C
Polyclonal antibodies against RNase L. Subcellular localization of this enzyme in mouse cells.
The Journal of biological chemistry 1991;266(9):5808-13.
1991: Degols G; Leonetti J P; Mechti N; Lebleu B
Antiproliferative effects of antisense oligonucleotides directed to the RNA of c-myc oncogene.
Nucleic acids research 1991;19(4):945-8.
1991: Roy C; Lebleu B
DNA protein interactions at the interferon-responsive promoter elements: potential for an H-DNA conformation.
Nucleic acids research 1991;19(3):517-24.
1991: Mechti N; Leonetti J P; Clarenc J P; Degols G; Lebleu B
Nuclear location of synthetic oligonucleotides microinjected somatic cells: its implication in an antisense strategy.
Nucleic acids symposium series 1991;(24):147-50.
1990: Leonetti J P; Machy P; Degols G; Lebleu B; Leserman L
Antibody-targeted liposomes containing oligodeoxyribonucleotides complementary to viral RNA selectively inhibit viral replication.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(7):2448-51.
1990: Roy C; Lebleu B
DNA-protein interactions at the interferon-responsive promoter: evidences for an involvement of phosphorylation.
Nucleic acids research 1990;18(8):2125-31.
1990: Charachon G; Sobol R W; Bisbal C; Salehzada T; Silhol M; Charubala R; Pfleiderer W; Lebleu B; Suhadolnik R J
Phosphorothioate analogues of (2'-5')(A)4: agonist and antagonist activities in intact cells.
Biochemistry 1990;29(10):2550-6.
1990: Leonetti J P; Degols G; Lebleu B
Biological activity of oligonucleotide-poly(L-lysine) conjugates: mechanism of cell uptake.
Bioconjugate chemistry 1990;1(2):149-53.
1990: Leserman L; Machy P; Leonetti J P; Milhaud P G; Degols G; Lebleu B
Targeted liposomes and intracellular delivery of macromolecules.
Progress in clinical and biological research 1990;343():95-102.
1989: Milhaud P G; Machy P; Lebleu B; Leserman L
Antibody targeted liposomes containing poly(rI).poly(rC) exert a specific antiviral and toxic effect on cells primed with interferons alpha/beta or gamma.
Biochimica et biophysica acta 1989;987(1):15-20.
1989: Degols G; Leonetti J P; Gagnor C; Lemaitre M; Lebleu B
Antiviral activity and possible mechanisms of action of oligonucleotides-poly(L-lysine) conjugates targeted to vesicular stomatitis virus mRNA and genomic RNA.
Nucleic acids research 1989;17(22):9341-50.
1989: Roy C; Lebleu B
Interferon-induced early changes in nuclear protein interactions with the interferon consensus sequence.
Biochemical and biophysical research communications 1989;163(1):370-7.
1989: Gagnor C; Rayner B; Leonetti J P; Imbach J L; Lebleu B
Alpha-DNA.IX: Parallel annealing of alpha-anomeric oligodeoxyribonucleotides to natural mRNA is required for interference in RNase H mediated hydrolysis and reverse transcription.
Nucleic acids research 1989;17(13):5107-14.
1989: Bisbal C; Salehzada T; Lebleu B; Bayard B
Characterization of two murine (2'-5')(A)n-dependent endonucleases of different molecular mass.
European journal of biochemistry / FEBS 1989;179(3):595-602.
1988: Leonetti J P; Rayner B; Lemaitre M; Gagnor C; Milhaud P G; Imbach J L; Lebleu B
Antiviral activity of conjugates between poly(L-lysine) and synthetic oligodeoxyribonucleotides.
Gene 1988;72(1-2):323-32.
1988: Piechaczyk M; Blanchard J M; Bonnieu A; Fort P; Mechti N; Rech J; Cuny M; Marty L; Ferré F; Lebleu B
Role of RNA structures in c-myc and c-fos gene regulations.
Gene 1988;72(1-2):287-95.
1988: Blanchard J M; Piechaczyk M; Fort P; Bonnieu A; Mechti N; Rech J; Cuny M; Lebleu B; Jeanteur P
The regulatory strategies of c-myc and c-fos proto-oncogenes share some common mechanisms.
Biochimie 1988;70(7):877-84.
1988: Mechti N; Bisbal C; Leonetti J P; Salehzada T; Affabris E; Bayard B; Piechaczyk M; Blanchard J M; Jeanteur P; Lebleu B
Interferons and oncogenes in the control of cell growth and differentiation: working hypothesis and experimental facts.
Biochimie 1988;70(7):869-75.
1987: Gagnor C; Bertrand J R; Thenet S; Lemaître M; Morvan F; Rayner B; Malvy C; Lebleu B; Imbach J L; Paoletti C
alpha-DNA. VI: Comparative study of alpha- and beta-anomeric oligodeoxyribonucleotides in hybridization to mRNA and in cell free translation inhibition.
Nucleic acids research 1987;15(24):10419-36.
1987: Bisbal C; Silhol M; Lemaître M; Bayard B; Salehzada T; Lebleu B; Perrée T D; Blackburn M G
5'-modified agonist and antagonist (2'-5')(A)n analogues: synthesis and biological activity.
Biochemistry 1987;26(16):5172-8.
1987: Milhaud P G; Silhol M; Salehzada T; Lebleu B
Requirement for endocytosis of poly(rI).poly(rC) to generate toxicity on interferon-treated LM cells.
The Journal of general virology 1987;68 ( Pt 4)():1125-34.
1987: Lemaitre M; Bayard B; Lebleu B
Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(3):648-52.
1986: Mechti N; Piechaczyk M; Blanchard J M; Marty L; Bonnieu A; Jeanteur P; Lebleu B
Transcriptional and post-transcriptional regulation of c-myc expression during the differentiation of murine erythroleukemia Friend cells.
Nucleic acids research 1986;14(24):9653-66.
1986: Silhol M; Huez G; Lebleu B
An antiviral state induced in HeLa cells by microinjected poly(rI).poly(rC).
The Journal of general virology 1986;67 ( Pt 9)():1867-73.
1986: Bayard B; Bisbal C; Lebleu B
Activation of ribonuclease L by (2'-5')(A)4-poly(L-lysine) conjugates in intact cells.
Biochemistry 1986;25(12):3730-6.
1985: Bayard B; Leserman L D; Bisbal C; Lebleu B
Antiviral activity in L1210 cells of liposome-encapsulated (2'-5')oligo(adenylate) analogues.
European journal of biochemistry / FEBS 1985;151(2):319-25.
1985: Dani C; Mechti N; Piechaczyk M; Lebleu B; Jeanteur P; Blanchard J M
Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(15):4896-9.
1985: Rossi G B; Affabris E; Romeo G; Federico M; Coccia E; Mechti N; Lebleu B
The role of two interferon-induced enzymatic activities in erythroid differentiation of Friend cells.
Progress in clinical and biological research 1985;202():285-96.
1985: Salehzada T; Blanchard J M; Mechti N; Piechaczyk M; Dani C; Jeanteur P; Lebleu B
Regulation of c-myc expression by IFN in Burkitt's lymphoma cells.
Progress in clinical and biological research 1985;202():211-7.
1985: Bisbal C; Bayard B; Silhol M; Leserman L; Lebleu B
2'5' Oligoadenylate analogues:synthesis, biological activities and intracellular delivery.
Progress in clinical and biological research 1985;202():89-95.
1985: Mechti N; Affabris E; Romeo G; Lebleu B
Subcellular distribution of 2',5'-oligoadenylate synthetase in differentiating Friend leukemia cells.
Differentiation; research in biological diversity 1985;29(2):136-9.
1984: Bayard B; Bisbal C; Silhol M; Cnockaert J; Huez G; Lebleu B
Increased stability and antiviral activity of 2'-O-phosphoglyceryl derivatives of (2'-5')oligo(adenylate).
European journal of biochemistry / FEBS 1984;142(2):291-8.
1984: Mechti N; Affabris E; Romeo G; Lebleu B; Rossi G B
Role of interferon and 2',5'-oligoadenylate synthetase in erythroid differentiation of Friend leukemia cells. Studies with interferon-sensitive and -resistant variants.
The Journal of biological chemistry 1984;259(5):3261-5.
1984: Faure T; Milhaud P G; Fruteau de Laclos H; Mechti N; Silhol M; Huez G; Lebleu B
Isolation and biological characterization of mouse LM fibroblast variants resistant to the cytotoxicity of polyriboinosinic polyribocytidylic acid after interferon treatment.
The Journal of general virology 1984;65 ( Pt 3)():617-27.
1983: Tovey M G; Dron M; Mogensen K E; Lebleu B; Mechti N; Begonlours-Guymarho J
Isolation of Daudi cells with reduced sensitivity to interferon. II. On the mechanisms of resistance.
The Journal of general virology 1983;64 ( Pt 12)():2649-53.
1983: Milhaud P G; Faure T; Chaintreuil J; Cathala J M; Lebleu B
Responses to interferon of LM cells growing continuously in the absence of serum and exogenous lipids.
The Journal of general virology 1983;64 (Pt 2)():485-9.
1983: Huez G; Silhol M; Lebleu B
Microinjected interferon does not promote an antiviral response in Hela cells.
Biochemical and biophysical research communications 1983;110(1):155-60.
1981: Marti J; Vandenbussche P; Silhol M; Milhaud P; Verhaegen M; Content J; Lebleu B
Effects of interferon on sensitive and resistant L1210 cell lines.
Journal of interferon research 1981;1(2):287-95.

Sign-in to see more